These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 25720243)
1. [Neurocognitive impairments of HIV infected individuals -- preliminary results of a national prevalence study in Hungary]. Lakatos B; Szabó Z; Bozzai B; Bánhegyi D; Gazdag G Ideggyogy Sz; 2014 Nov; 67(11-12):409-14. PubMed ID: 25720243 [TBL] [Abstract][Full Text] [Related]
2. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil. Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557 [TBL] [Abstract][Full Text] [Related]
3. Effect of age and level of education on neurocognitive impairment in HIV positive Zambian adults. Kabuba N; Menon JA; Franklin DR; Lydersen S; Heaton RK; Hestad KA Neuropsychology; 2018 Jul; 32(5):519-528. PubMed ID: 29504779 [TBL] [Abstract][Full Text] [Related]
4. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study. Lawler K; Mosepele M; Ratcliffe S; Seloilwe E; Steele K; Nthobatsang R; Steenhoff A J Int AIDS Soc; 2010 Apr; 13():15. PubMed ID: 20406460 [TBL] [Abstract][Full Text] [Related]
5. Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe. Nyamayaro P; Gouse H; Hakim J; Robbins RN; Chibanda D BMC Infect Dis; 2020 May; 20(1):383. PubMed ID: 32471350 [TBL] [Abstract][Full Text] [Related]
6. Neurocognitive Impairment in the Combined Antiretroviral Therapy Era in a Romanian Cohort of Young Adults with Chronic HIV Infection. Temereanca A; Ene L; Rosca A; Diaconu CC; Luca A; Burlacu R; Radoi R; Bulacu-Talnariu A; Marcotte TD; Achim CL; Ruta S AIDS Res Hum Retroviruses; 2020 May; 36(5):367-372. PubMed ID: 31476875 [TBL] [Abstract][Full Text] [Related]
7. Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. Ciccarelli N; Fabbiani M; Di Giambenedetto S; Fanti I; Baldonero E; Bracciale L; Tamburrini E; Cauda R; De Luca A; Silveri MC Neurology; 2011 Apr; 76(16):1403-9. PubMed ID: 21502598 [TBL] [Abstract][Full Text] [Related]
8. Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients. Grima P; Fabbiani M; Ciccarelli N; Tana M; Farina S; Colafigli M; Mondi A; Cauda R; Di Giambenedetto S J Infect; 2012 Nov; 65(5):439-46. PubMed ID: 22863903 [TBL] [Abstract][Full Text] [Related]
9. Neurocognitive profile of HIV-positive adults on combined antiretroviral therapy: A single-centre study in Serbia. Malagurski B; Bugarski Ignjatović V; Marić D; Nikolašević Ž; Mihić L; Brkić S Appl Neuropsychol Adult; 2018; 25(6):513-522. PubMed ID: 28665215 [TBL] [Abstract][Full Text] [Related]
11. Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia. Ciccarelli N; Fabbiani M; Colafigli M; Trecarichi EM; Silveri MC; Cauda R; Murri R; De Luca A; Di Giambenedetto S Antivir Ther; 2013; 18(2):153-60. PubMed ID: 23486721 [TBL] [Abstract][Full Text] [Related]
12. Factors related to HIV-associated neurocognitive impairment differ with age. Fogel GB; Lamers SL; Levine AJ; Valdes-Sueiras M; McGrath MS; Shapshak P; Singer EJ J Neurovirol; 2015 Feb; 21(1):56-65. PubMed ID: 25404233 [TBL] [Abstract][Full Text] [Related]
13. Preliminary study of a novel cognitive assessment device for the evaluation of HIV-associated neurocognitive impairment. Anderson AM; Lennox JL; Nguyen ML; Waldrop-Valverde D; Tyor WR; Loring DW J Neurovirol; 2016 Dec; 22(6):816-822. PubMed ID: 27245594 [TBL] [Abstract][Full Text] [Related]
14. Empiric neurocognitive performance profile discovery and interpretation in HIV infection. Gomez D; Power C; Gill MJ; Koenig N; Vega R; Fujiwara E J Neurovirol; 2019 Feb; 25(1):72-84. PubMed ID: 30519968 [TBL] [Abstract][Full Text] [Related]
15. Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapy. Garvey L; Surendrakumar V; Winston A HIV Clin Trials; 2011; 12(6):333-8. PubMed ID: 22189152 [TBL] [Abstract][Full Text] [Related]
16. Correlations between computerized battery testing and a memory questionnaire for identification of neurocognitive impairment in HIV type 1-infected subjects on stable antiretroviral therapy. Garvey LJ; Yerrakalva D; Winston A AIDS Res Hum Retroviruses; 2009 Aug; 25(8):765-9. PubMed ID: 19678764 [TBL] [Abstract][Full Text] [Related]
17. Accelerated and accentuated neurocognitive aging in HIV infection. Sheppard DP; Iudicello JE; Morgan EE; Kamat R; Clark LR; Avci G; Bondi MW; Woods SP; J Neurovirol; 2017 Jun; 23(3):492-500. PubMed ID: 28321696 [TBL] [Abstract][Full Text] [Related]
19. Depression and neurocognitive performance in Portuguese patients infected with HIV. Bragança M; Palha A AIDS Behav; 2011 Nov; 15(8):1879-87. PubMed ID: 21598031 [TBL] [Abstract][Full Text] [Related]
20. Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong - a single center study. Chan FCC; Chan P; Chan I; Chan A; Tang THC; Lam W; Fong WC; Lee MP; Li P; Chan GHF BMC Infect Dis; 2019 Feb; 19(1):156. PubMed ID: 30760220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]